Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Site search
Search
Menu
Subscribe
Home
Contact Us
Terms of Use
Privacy Policy
Home Delivery
Subscribe
Submission Forms
Place an Ad
Weather
News
Sports
Entertainment
Calendar
Obituaries
Classifieds
Place an ad
e-Edition
Best of 2023
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Resmed Inc
(NY:
RMD
)
216.98
-1.17 (-0.54%)
Official Closing Price
Updated: 4:10 PM EDT, May 3, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Resmed Inc
< Previous
1
2
3
4
5
6
7
8
9
10
Next >
How Sleep Device Player ResMed Is Gaining Philips' Market Share In Flow Generator Market - Analysts Weigh In
October 27, 2023
Needham analyst Mike Matson reiterated a Buy rating on ResMed Inc. (NYSE: RMD)
Via
Benzinga
Weight-Loss Drugs Spooked Medical Device Stocks. Did Investors Overreact?
October 27, 2023
Makers of devices to treat obesity-related conditions have struggled recently. Analysts say there's more to the story.
Via
Investor's Business Daily
ResMed Inc. Announces Results for the First Quarter of Fiscal Year 2024
October 26, 2023
From
ResMed Inc.
Via
GlobeNewswire
3 Stocks to Buy From the ‘Buy the Dip’ ETF
October 23, 2023
It’s a lot harder than it looks to buy the dip. Using artificial intelligence to do this makes these three stocks a buy.
Via
InvestorPlace
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Is NYSE:RMD a Good Fit for Dividend Investing?
October 18, 2023
Analyzing RESMED INC (NYSE:RMD)'s Dividend Potential.
Via
Chartmill
Expert Ratings for ResMed
October 12, 2023
Via
Benzinga
What 6 Analyst Ratings Have To Say About ResMed
September 05, 2023
Via
Benzinga
Earnings Scheduled For October 26, 2023
October 26, 2023
Companies Reporting Before The Bell • TotalEnergies (NYSE:TTE) is likely to report quarterly earnings at $2.57 per share on revenue of $49.83 billion.
Via
Benzinga
Exxon Mobil To Rally Around 23%? Here Are 10 Other Analyst Forecasts For Thursday
October 12, 2023
Cantor Fitzgerald cut Hyliion Holdings Corp. (NYSE: HYLN) price target from $2 to $1. Cantor Fitzgerald analyst Andres Sheppard downgraded the stock from Neutral to Underweight. Hyliion shares fell...
Via
Benzinga
The Latest Analyst Ratings for ResMed
August 14, 2023
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For October 12, 2023
October 12, 2023
Via
Benzinga
ResMed to Report First Quarter Fiscal 2024 Earnings on October 26, 2023
October 05, 2023
From
ResMed Inc.
Via
GlobeNewswire
Benzinga's Top Ratings Upgrades, Downgrades For September 29, 2023
September 29, 2023
Via
Benzinga
10 Health Care Stocks Whale Activity In Today's Session
September 18, 2023
Via
Benzinga
3 Top Growth Stock Picks Trading at a Massive Bargain
September 13, 2023
These growth stock picks are trading at bargain prices and are well-positioned to rebound and deliver substantial gains in the coming months.
Via
InvestorPlace
Stocks That Hit 52-Week Lows On Friday
September 15, 2023
Friday's session saw 169 companies set new 52-week lows.
Via
Benzinga
Is It Time to Buy the S&P 500's 3 Worst-Performing August Stocks?
September 07, 2023
The S&P 500 had a rare decline last month.
Via
The Motley Fool
Topics
Stocks
Exposures
US Equities
Sleep Device Player ResMed's Potential Obstacles: Analyst Weighs Obesity Drugs & Philips' Re-Entry
September 06, 2023
Needham upgraded ResMed Inc (NYSE: RMD) from a Hold to Buy rating with a price target of $180
Via
Benzinga
Stocks That Hit 52-Week Lows On Thursday
September 07, 2023
On Thursday, 283 companies set new 52-week lows.
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 6, 2023
September 06, 2023
Via
Benzinga
ResMed Announces Participation in Upcoming Conferences
September 05, 2023
From
ResMed Inc.
Via
GlobeNewswire
Benzinga's Top Ratings Upgrades, Downgrades For September 5, 2023
September 05, 2023
Via
Benzinga
American Express To Rally Over 25%? Here Are 10 Other Analyst Forecasts For Tuesday
September 05, 2023
Wells Fargo raised the price target for Equity Residential (NYSE: EQR) from $62 to $69. Wells Fargo analyst James Feldman upgraded the stock from Equal-Weight to Overweight. Equity Residential shares...
Via
Benzinga
3 Reasons ResMed's CEO Isn't Worried About Ozempic or Wegovy
September 01, 2023
Mick Farrell might be kidding himself about the degree to which the popular weight-loss drugs will impact his company.
Via
The Motley Fool
Late-Summer Steals: 7 Stocks to Buy Before Fall
August 28, 2023
With the summer season coming to an end and investors returning from vacation, it’s time to consider these stocks to buy now.
Via
InvestorPlace
3 Growth Stocks That Can Soar 50%, According to Wall Street
August 25, 2023
Are these stocks the slam-dunk buys analysts think they are?
Via
The Motley Fool
Stocks That Hit 52-Week Lows On Wednesday
August 23, 2023
Wednesday's session saw 150 companies set new 52-week lows.
Via
Benzinga
Buy the Drop: 3 Stocks to Snag After This Month’s 20% Tumble
August 21, 2023
With plenty of companies having their share prices corrected in August, it's time to shop for bargain stocks to buy on the dip.
Via
InvestorPlace
5 Blue-Chip Stocks AI Thinks Will Double Your Money by 2027
August 16, 2023
Blue-chip stocks are traditionally market laggards, but the MarketMaster AI is flashing major "buy" signals in these 5 names right now.
Via
InvestorPlace
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
2 Stocks That Could Grow Your Portfolio Over the Next Decade
August 15, 2023
These two promising stocks could help your portfolio grow steadily over the long term.
Via
The Motley Fool
< Previous
1
2
3
4
5
6
7
8
9
10
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.